(Q36055562)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15733211%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

review article

1 reference

title

Prediction of drug metabolism and interactions on the basis of in vitro investigations (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15733211%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

Jouko Uusitalo

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15733211%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Arja Rautio

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15733211%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Hannu Raunio

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15733211%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

publication date

1 March 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15733211%20AND%20SRC:MED&resulttype=core&format=json

Basic and Clinical Pharmacology and Toxicology

8 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15733211%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

96

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15733211%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15733211%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

167-175

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15733211%20AND%20SRC:MED&resulttype=core&format=json

An update on in vitro test methods in human hepatic drug biotransformation research: pros and cons

8 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO960305.X

Progress towards prediction of human pharmacokinetic parameters from in vitro technologies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO960305.X

Polymorphic human cytochrome P450 enzymes: an opportunity for individualized drug treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO960305.X

Database analyses for the prediction of in vivo drug-drug interactions from in vitro data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO960305.X

Quantitative prediction of in vivo drug clearance and drug interactions from in vitro data on metabolism, together with binding and transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO960305.X

Liquid chromatography/atmospheric pressure ionization-mass spectrometry in drug metabolism studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO960305.X

In vitro tests for predicting drug-drug interactions: the need for validated procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO960305.X

LC/MS applications in drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO960305.X

Screening for human ADME/Tox drug properties in drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO960305.X

Strategies for dealing with metabolite elucidation in drug discovery and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO960305.X

Clinical importance of the cytochromes P450

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO960305.X

Inhibition and induction of human cytochrome P450 (CYP) enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO960305.X

Carbamazepine: a 'blind' assessment of CVP-associated metabolism and interactions in human liver-derived in vitro systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO960305.X

Strategies for using in vitro screens in drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO960305.X

Comparative studies on the cytochrome p450-associated metabolism and interaction potential of selegiline between human liver-derived in vitro systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO960305.X

Utility of physiologically based pharmacokinetic models to drug development and rational drug discovery candidate selection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO960305.X

ADMET in silico modelling: towards prediction paradise?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO960305.X

In vitro approaches to predicting drug interactions in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO960305.X

High-throughput screening in drug metabolism and pharmacokinetic support of drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO960305.X

Introductory remarks on human CYPs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2005.PTO960305.X